Establishment Labs announced that the Motiva Flora SmoothSilk Tissue Expander was used for the first time in the United States at the University of Texas MD Anderson Cancer Center in Houston by Mark Clemens, Professor of Plastic Surgery. The recent FDA clearance and first procedure mark significant developments in the field of plastic and reconstructive surgery.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ESTA:
- 3 Best Stocks to Buy Now, 12/25/2023, According to Top Analysts
- Establishment Labs management to meet with BTIG
- Establishment Labs price target lowered to $50 from $95 at B. Riley
- Establishment Labs gets NMPA approval in China for Motiva Implants
- JPMorgan ‘encouraged’ by Establishment Labs rally after Motiva China approval
